WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2020

May 12, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2020-05-08

Reporting Person: Abraham Silji (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-05-08	Common Stock	M	1000.00	$86.24	Acquired	6894.2997	Direct
2020-05-08	Common Stock	S	1000.00	$200.00	Disposed	5894.2997	Direct
2020-05-11	Common Stock	M	1000.00	$86.24	Acquired	6894.2997	Direct
2020-05-11	Common Stock	S	1000.00	$204.50	Disposed	5894.2997	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-05-08	Stock Options (Right to Buy)	$86.24	M	1000.00	Disposed	2028-02-26	Common Stock (1000.00)	Direct
2020-05-11	Stock Options (Right to Buy)	$86.24	M	1000.00	Disposed	2028-02-26	Common Stock (1000.00)	Direct

Footnotes

F1: This award vests in 4 equal annual installments beginning on 2/26/2019.